A Valuable COVID Drug Doesn’t Work against New Variants
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
Featured Articles
Tons of COVID Medical Garbage Threaten Health
Burning piles of used gloves, test kits and syringes release toxic pollutants. But there are ways to improve medical recycling
Looks like non-mRNA vaccines can be as good as Pfizer and Moderna in certain scenarios
A new study in Mexico shows that non-mRNA vaccines like the Russian version can be as effective as mRNA vaccines like Pfizer if the patient has previously been infected with SARS-CoV-2.
Scientists Square Off Over Covid, Wuhan, and Peter Daszak
A group of academics claim the president of EcoHealth Alliance has misled the public amid Covid origins investigations.
Gain-of-Function Research: All in the Eye of the Beholder
Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
Fauci on COVID Drugs, Vaccines and Getting Back to Normal
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens